Larissa E. van Eijk

503 total citations
9 papers, 174 citations indexed

About

Larissa E. van Eijk is a scholar working on Infectious Diseases, Neurology and Surgery. According to data from OpenAlex, Larissa E. van Eijk has authored 9 papers receiving a total of 174 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 3 papers in Neurology and 1 paper in Surgery. Recurrent topics in Larissa E. van Eijk's work include COVID-19 Clinical Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Long-Term Effects of COVID-19 (3 papers). Larissa E. van Eijk is often cited by papers focused on COVID-19 Clinical Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Long-Term Effects of COVID-19 (3 papers). Larissa E. van Eijk collaborates with scholars based in Netherlands, United States and United Kingdom. Larissa E. van Eijk's co-authors include Arno R. Bourgonje, Harry van Goor, Jan‐Luuk Hillebrands, Peter H. J. van der Voort, Amaal Eman Abdulle, Wilfred F.A. den Dunnen, Eelke M. Bos, Nikola Kolundžić, Mathijs Binkhorst and Marcel G. M. Olde Rikkert and has published in prestigious journals such as Free Radical Biology and Medicine, Antioxidants and Redox Signaling and The Journal of Pathology.

In The Last Decade

Larissa E. van Eijk

6 papers receiving 172 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larissa E. van Eijk Netherlands 4 100 68 35 25 21 9 174
Xiaohua Peng China 6 98 1.0× 49 0.7× 55 1.6× 32 1.3× 32 1.5× 17 222
Tom Sasse Switzerland 5 161 1.6× 59 0.9× 48 1.4× 16 0.6× 12 0.6× 12 311
Alexandre Elabbadi France 7 96 1.0× 35 0.5× 31 0.9× 6 0.2× 35 1.7× 20 203
Sophia J. Kiechl Austria 7 52 0.5× 23 0.3× 39 1.1× 9 0.4× 64 3.0× 19 205
Nicolas Carlier France 9 81 0.8× 41 0.6× 42 1.2× 3 0.1× 27 1.3× 18 175
Salma Mujib United Kingdom 4 94 0.9× 85 1.3× 75 2.1× 2 0.1× 66 3.1× 6 239
Christina Damoulari Greece 3 46 0.5× 19 0.3× 25 0.7× 40 1.6× 27 1.3× 7 99
J Skrha Czechia 5 67 0.7× 29 0.4× 27 0.8× 3 0.1× 18 0.9× 8 155
Wenhua Liu China 2 147 1.5× 50 0.7× 49 1.4× 2 0.1× 17 0.8× 3 202
Konstantina Katrini Greece 5 29 0.3× 21 0.3× 35 1.0× 51 2.0× 21 1.0× 6 123

Countries citing papers authored by Larissa E. van Eijk

Since Specialization
Citations

This map shows the geographic impact of Larissa E. van Eijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larissa E. van Eijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larissa E. van Eijk more than expected).

Fields of papers citing papers by Larissa E. van Eijk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larissa E. van Eijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larissa E. van Eijk. The network helps show where Larissa E. van Eijk may publish in the future.

Co-authorship network of co-authors of Larissa E. van Eijk

This figure shows the co-authorship network connecting the top 25 collaborators of Larissa E. van Eijk. A scholar is included among the top collaborators of Larissa E. van Eijk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larissa E. van Eijk. Larissa E. van Eijk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Eijk, Larissa E. van, et al.. (2025). Post‐COVID‐19 condition: clinical phenotypes, pathophysiological mechanisms, pathology, and management strategies. The Journal of Pathology. 266(4-5). 369–389. 1 indexed citations
2.
Eijk, Larissa E. van, María F. Vincenti‐González, A.C.M. Veloo, et al.. (2024). Temporal Dynamics and (Para)Clinical Factors Associated With (Long) Viral RNA Shedding in COVID‐19 Nonhospitalized Individuals – The COVID‐HOME Study. Journal of Medical Virology. 96(12). e70125–e70125.
3.
Eijk, Larissa E. van, Arno R. Bourgonje, A. Lianne Messchendorp, et al.. (2024). Systemic oxidative stress may be associated with reduced IgG antibody titers against SARS-CoV-2 in vaccinated kidney transplant recipients: A post-hoc analysis of the RECOVAC-IR observational study. Free Radical Biology and Medicine. 215. 14–24.
4.
Ghoti, Hussam, Arno R. Bourgonje, Arjan Diepstra, et al.. (2023). Clinical outcome and humoral immune responses of β-thalassemia major patients with severe iron overload to SARS-CoV-2 infection and vaccination: a prospective cohort study. EClinicalMedicine. 62. 102096–102096. 2 indexed citations
5.
Eijk, Larissa E. van, et al.. (2022). The Disease-Modifying Role of Taurine and Its Therapeutic Potential in Coronavirus Disease 2019 (COVID-19). Advances in experimental medicine and biology. 1370. 3–21. 5 indexed citations
6.
Eijk, Larissa E. van, Mathijs Binkhorst, Arno R. Bourgonje, et al.. (2021). COVID‐19: immunopathology, pathophysiological mechanisms, and treatment options. The Journal of Pathology. 254(4). 307–331. 103 indexed citations
7.
Bourgonje, Arno R., Larissa E. van Eijk, Amaal Eman Abdulle, et al.. (2021). N-Acetylcysteine and Hydrogen Sulfide in Coronavirus Disease 2019. Antioxidants and Redox Signaling. 35(14). 1207–1225. 45 indexed citations
8.
Eijk, Larissa E. van, et al.. (2021). A Rare Case of Epstein-Barr Virus–Positive T-Cell Lymphoma in the Skin of an Immunocompromised Patient. American Journal of Dermatopathology. 44(2). e19–e22.
9.
Eijk, Larissa E. van, Adriana Tami, Jan‐Luuk Hillebrands, et al.. (2021). Mild Coronavirus Disease 2019 (COVID-19) Is Marked by Systemic Oxidative Stress: A Pilot Study. Antioxidants. 10(12). 2022–2022. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026